Sabinsa Hosts Industry Meeting on GSK Petition at SupplySide: Trade Association Heads to Give Update, Call to Action

Sabinsa Hosts Industry Meeting on GSK Petition at SupplySide: Trade Association Heads to Give Update, Call to Action

Sabinsa Corporation is hosting an industry meeting to discuss the Citizen Petition filed by Glaxo Smith Klein (GSK) at Virgo Publishing’s SupplySide West on Thursday, October 23, 2008 from 4:00 -5:00 pm in Casanova Rm. 601, Sands Exposition Center, Las Vegas, NV

Speakers will include David Seckman, Executive Director / CEO, Natural Products Association; Michael McGuffin, President, American Herbal Products Association; Loren Israelsen, United Natural Products Alliance; Steven Mister, Executive Director, Council for Responsible Nutrition; and industry regulatory attorney Marc Ullman, Ullman Shapiro Ullman, who drafted Sabinsa’s comments. All members of industry are invited, and encouraged, to attend.

While the industry’s trade associations have filed comments with the FDA objecting to the GSK Petition, as have many health food store owners and consumers, few manufacturers have done so. Sabinsa is one of the few companies that have filed substantive comments with the FDA on this matter.

“It is time for the industry to put a stop to assaults on our credibility.” said company CEO Jeff Lind. “Sabinsa’s making the investment in submitting comprehensive comments is the responsible thing to do in order to protect our interests and the consumer’s access to safe and effective products. Other manufacturers have the responsibility to participate, which is why we are putting the best heads together to provide guidance and perspective submitting comments and discuss the role this petition plays in a larger attempt to undermine our industry.”

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals.

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past 20 years, Sabinsa has brought to market more than 100 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 80 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher, with some certified Halal.

For more information stop by the Sabinsa booth # 21051 at SupplySide West or visit

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.